Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
STADA Arzneimittel Aktiengesellschaft
Pharmaceutical Preparation ManufacturingGermanyCRYPTO: INSTUSD
Last verified 2 months agostada.de
STADA Arzneimittel Aktiengesellschaft, commonly referred to as STADA, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in Germany. Founded in 1895, the company has established a strong presence across Europe and beyond, focusing on the development and production of high-quality generic and over-the-counter (OTC) products.
STADA's core offerings include a diverse range of pharmaceuticals, particularly in the areas of pain relief, allergy treatment, and dermatology. What sets STADA apart is its commitment to quality and accessibility, ensuring that essential medications are available to a broad audience. With a robust market position, STADA has achieved significant milestones, including strategic acquisitions that have expanded its product portfolio and global reach. As a trusted name in the pharmaceutical sector, STADA continues to innovate and adapt to meet the evolving needs of healthcare providers and patients alike.
58
DitchCarbon score
+16 vs industry average
STADA Arzneimittel Aktiengesellschaft’s score of 58 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at STADA Arzneimittel Aktiengesellschaft?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
STADA Arzneimittel Aktiengesellschaft's reported carbon emissions
STADA Arzneimittel Aktiengesellschaft, headquartered in Germany and operating in Pharmaceutical Preparation Manufacturing, has set climate commitments to reduce its carbon emissions.
For the year 2025, STADA projects total emissions of approximately 739.8 million kg CO2e. This includes about 42.8 million kg CO2e from Scope 1 emissions, approximately 26.1 million kg CO2e from market-based Scope 2 emissions, and around 670.9 million kg CO2e from Scope 3 emissions. Key contributors to Scope 3 emissions in 2025 are purchased goods and services (approximately 566.5 million kg CO2e), upstream transportation and distribution (approximately 38.5 million kg CO2e), and fuel and energy-related activities (approximately 33.3 million kg CO2e).
In 2024, STADA reported Scope 1 emissions of approximately 40.9 million kg CO2e and market-based Scope 2 emissions of about 29.9 million kg CO2e.
For 2023, STADA reported total emissions of about 754.7 million kg CO2e. This comprised approximately 40.1 million kg CO2e from Scope 1 emissions, around 41.7 million kg CO2e from market-based Scope 2 emissions, and about 672.8 million kg CO2e from Scope 3 emissions. Significant Scope 3 categories included purchased goods and services (approximately 574.8 million kg CO2e), upstream transportation and distribution (approximately 41.6 million kg CO2e), and fuel and energy-related activities (approximately 31.6 million kg CO2e).
STADA has committed to an absolute reduction target for its Scope 1 and 2 emissions. The company aims to decrease these emissions by 42% by 2030, using 2020 as the baseline year. This commitment aligns with the 1.5°C global warming target and includes efforts to increase renewable energy use and energy efficiency. STADA's near-term targets for both Scope 1 and Scope 2 emissions are currently classified as "Committed" by the Science Based Targets initiative (SBTi).
Assessing STADA Arzneimittel Aktiengesellschaft as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for STADA Arzneimittel Aktiengesellschaft and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
STADA Arzneimittel Aktiengesellschaft’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
7 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
STADA Arzneimittel Aktiengesellschaft2 months ago
58
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about STADA Arzneimittel Aktiengesellschaft’s sustainability data and climate commitments
For the projected year 2025, STADA Arzneimittel Aktiengesellschaft anticipates total carbon emissions of approximately 740 million kg CO2e. The largest portion, around 671 million kg CO2e, stems from Scope 3 emissions, primarily driven by purchased goods and services. Scope 1 emissions are estimated at about 43 million kg CO2e, and market-based Scope 2 emissions are projected to be nearly 26 million kg CO2e. This breakdown highlights the significant influence of the company's value chain on its overall carbon footprint.
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more